Cargando…
A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades
The avian influenza virus outbreak in 1997 highlighted the potential of the highly pathogenic H5N1 virus to cause severe disease in humans. Therefore, effective vaccines against H5N1 viruses are needed to counter the potential threat of a global pandemic. We have previously developed a fast-acting a...
Autores principales: | Furuyama, Wakako, Reynolds, Pierce, Haddock, Elaine, Meade-White, Kimberly, Quynh Le, Mai, Kawaoka, Yoshihiro, Feldmann, Heinz, Marzi, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954110/ https://www.ncbi.nlm.nih.gov/pubmed/31934358 http://dx.doi.org/10.1038/s41541-019-0155-z |
Ejemplares similares
-
The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
por: Suder, Ellen, et al.
Publicado: (2018) -
Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
por: Marzi, Andrea, et al.
Publicado: (2015) -
A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
por: Safronetz, David, et al.
Publicado: (2015) -
Immunological correlates of protection afforded by PHV02 live, attenuated recombinant vesicular stomatitis virus vector vaccine against Nipah virus disease
por: Monath, Thomas P., et al.
Publicado: (2023) -
A live-attenuated viral vector vaccine protects mice against lethal challenge with Kyasanur Forest disease virus
por: Bhatia, Bharti, et al.
Publicado: (2021)